The Turku Site, with 580 employees, represents one of PerkinElmer’s major manufacturing and product development sites for newborn-, maternal fetal health-, and prenatal screening. As the global market leader in newborn screening, our solutions have tested over 560 million babies worldwide for life-threatening diseases.
The Turku HR team partners with local and global departments, and collaborates strongly to ensure that the current and future business requirements regarding all human resources aspects are met.
What we offer:
PerkinElmer Turku Site is a drug free site and a medical examination for new employees includes a drug test.
For more details, please contact recruiter Tuula Kukkonen (tel. +358 50 3270 327) on Friday, April 5th at 9.00 - 11.00. If you are interested in the position and feel that you have the necessary skills and experience, please send your application and CV as soon as possible via the link below.
PerkinElmer enables scientists, researchers and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, we deliver unique solutions to serve the diagnostics, life sciences, food and applied markets. We strategically partner with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Our dedicated team of 12,500 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $2.8 billion in 2018, serves customers in more than 150 countries, and is a component of the S&P 500 index.